Serial 98213149
Live / Applied — Third extension granted (statement of use) (as of 02 Mar 2026)
What this means for you
Not registered yet, but its 06 Oct 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98213149
- Mark type
- Design / logo
- Filed
- 06 Oct 2023
- Published for opposition
- 09 Jul 2024
- Attorney of record
- Randy Michels
Goods and services
- Class 005 — Pharmaceuticals: Neuro-regenerative pharmaceutical products for the treatment of nerve injuries
Owner
- Solaxa Inc., Chevy Chase, MD, US
- Solaxa Inc., Chevy Chase, MD, US
Prosecution history
- 03 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Mar 2026 — SOU EXTENSION 3 GRANTED
- 02 Mar 2026 — SOU EXTENSION 3 FILED
- 02 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 26 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Aug 2025 — SOU EXTENSION 2 GRANTED
- 25 Aug 2025 — SOU EXTENSION 2 FILED
- 25 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Feb 2025 — SOU EXTENSION 1 GRANTED
- 08 Feb 2025 — SOU EXTENSION 1 FILED
- 07 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Sept 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Jul 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jul 2024 — PUBLISHED FOR OPPOSITION